Rigel Pharma (RIGL) Enters Collaboration with Bristol-Myers (BMY) for TGF Beta Receptor Kinase Inhibitors
Tweet Send to a Friend
Rigel Pharma (NASDAQ: RIGL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that they have entered into a collaboration agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
